Expert consensus on personalized initiation of glucose-lowering therapy in adults with newly diagnosed type 2 diabetes without clinical cardiovascular disease or chronic kidney disease

Zhang, F; Ji, LN; Hong, TP; Guo, LX; Li, Y; Zhu, ZM; Liu, XB; Liu, F; Tang, LZ; Zhang, YW; Li, J; Lu, QG; Tong, NW

Tong, NW (通讯作者),Sichuan Univ, West China Hosp, Ctr Diabet & Metab Res, Div Endocrinol & Metab, 37 Guoxuexiang, Chengdu 610041, Sichuan, Peoples R China.

JOURNAL OF EVIDENCE BASED MEDICINE, 2022; 15 (2): 168